Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Remegen (9995 HK)
Watchlist
186
Analysis
Health Care
•
China
RemeGen Co., Ltd. operates biotechnology businesses. The Company develops therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. RemeGen provides solutions autoimmune diseases, tumor diseases, and ophthalmic diseases.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
22 Jul 2024 19:18
Voluntary Announcement - The Full Approval Of Telitacicept For The Treatment Of Patients With Rheumatoid Arthritis By Nmpa
Attachment
Exchange Announcement •
12 Jul 2024 06:04
Announcement - Unusual Movement In Trading Of Shares
Attachment
Exchange Announcement •
28 Jun 2024 22:15
Articles Of Association
Attachment
Exchange Announcement •
28 Jun 2024 22:08
Poll Results Of The 2023 Annual General Meeting
Attachment
Exchange Announcement •
17 Jun 2024 22:48
Poll Results Of The 2024 First Extraordinary General Meeting
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x